TY - JOUR
T1 - Interval estimation of the overall treatment effect in a meta-analysis of a few small studies with zero events
AU - Pateras, Konstantinos
AU - Nikolakopoulos, Stavros
AU - Mavridis, Dimitris
AU - Roes, Kit C.B.
N1 - Funding Information:
Konstantinos Pateras, Stavros Nikolakopulos and Kit Roes were supported by the EU FP7 HEALTH.2013.4.2-3 project Advances in Small Trials dEsign for Regulatory Innovation and eXcellence (Asterix): Grant 603160 . The authors would like to thank Putri W. Novianti for early discussions on the heterogeneity estimators.
Publisher Copyright:
© 2017
PY - 2018/3/1
Y1 - 2018/3/1
N2 - When a meta-analysis consists of a few small trials that report zero events, accounting for heterogeneity in the (interval) estimation of the overall effect is challenging. Typically, we predefine meta-analytical methods to be employed. In practice, data poses restrictions that lead to deviations from the pre-planned analysis, such as the presence of zero events in at least one study arm. We aim to explore heterogeneity estimators behaviour in estimating the overall effect across different levels of sparsity of events. We performed a simulation study that consists of two evaluations. We considered an overall comparison of estimators unconditional on the number of observed zero cells and an additional one by conditioning on the number of observed zero cells. Estimators that performed modestly robust when (interval) estimating the overall treatment effect across a range of heterogeneity assumptions were the Sidik-Jonkman, Hartung-Makambi and improved Paul-Mandel. The relative performance of estimators did not materially differ between making a predefined or data-driven choice. Our investigations confirmed that heterogeneity in such settings cannot be estimated reliably. Estimators whose performance depends strongly on the presence of heterogeneity should be avoided. The choice of estimator does not need to depend on whether or not zero cells are observed.
AB - When a meta-analysis consists of a few small trials that report zero events, accounting for heterogeneity in the (interval) estimation of the overall effect is challenging. Typically, we predefine meta-analytical methods to be employed. In practice, data poses restrictions that lead to deviations from the pre-planned analysis, such as the presence of zero events in at least one study arm. We aim to explore heterogeneity estimators behaviour in estimating the overall effect across different levels of sparsity of events. We performed a simulation study that consists of two evaluations. We considered an overall comparison of estimators unconditional on the number of observed zero cells and an additional one by conditioning on the number of observed zero cells. Estimators that performed modestly robust when (interval) estimating the overall treatment effect across a range of heterogeneity assumptions were the Sidik-Jonkman, Hartung-Makambi and improved Paul-Mandel. The relative performance of estimators did not materially differ between making a predefined or data-driven choice. Our investigations confirmed that heterogeneity in such settings cannot be estimated reliably. Estimators whose performance depends strongly on the presence of heterogeneity should be avoided. The choice of estimator does not need to depend on whether or not zero cells are observed.
KW - Heterogeneity
KW - Meta-analysis
KW - Rare diseases
KW - Small populations
KW - Zero events
UR - http://www.scopus.com/inward/record.url?scp=85040325683&partnerID=8YFLogxK
U2 - 10.1016/j.conctc.2017.11.012
DO - 10.1016/j.conctc.2017.11.012
M3 - Article
AN - SCOPUS:85040325683
SN - 2451-8654
VL - 9
SP - 98
EP - 107
JO - Contemporary Clinical Trials Communications
JF - Contemporary Clinical Trials Communications
ER -